GABAB receptor modulation of visual sensory processing in adults with and without autism spectrum disorder.
Clinical Research Associates
A phase II randomized, double-blind, placebo-controlled study of the efficacy, safety, and tolerability of arbaclofen administered for the treatment of social function in children and adolescents with autism spectrum disorders: Study protocol for AIMS-2-TRIALS-CT1.
GABAB receptor agonist R-baclofen reverses altered auditory reactivity and filtering in the Cntnap2 knock-out rat.